Search research articles
Contact Us
Filters
Showing results (11-20 of 107) with videos related to
Page
of 11
Sort By:
The Journal of Experimental Medicine
|
December 1, 1971
The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective foci
R J North
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients
R J North
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression
R J North
Infection and Immunity
|
July 1, 1974
T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis
R J North
Infection and Immunity
|
September 1, 1974
Inflammatory lymphocyte in cell-mediated antibacterial immunity: factors governing the accumulation of mediator T cells in peritoneal exudates
R J North, G Spitalny
Immunology
|
September 1, 1990
Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma
R J North, M Awwad
The Journal of Experimental Medicine
|
October 1, 1986
T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity
A DiGiacomo, R J North
Immunology
|
March 1, 1987
Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumour
A Digiacomo, R J North
International Journal of Cancer
|
February 15, 1986
Immunological consequences of tumor excision: from active immunity to immunological memory
I Bursuker, R J North
The Journal of Experimental Medicine
|
December 1, 1988
Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity
M Awwad, R J North
Page
of 11
Search research articles
Search
Showing results (11-20 of 107) with videos related to
Sort By:
Page
of 11
The Journal of Experimental Medicine
|
December 1, 1971
The action of cortisone acetate on cell-mediated immunity to infection. Suppression of host cell proliferation and alteration of cellular composition of infective foci
R J North
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The therapeutic significance of concomitant antitumor immunity. I. LY-1-2+ T cells from mice with a progressive tumor can cause regression of an established tumor in gamma-irradiated recipients
R J North
Cancer Immunology, Immunotherapy : CII
|
January 1, 1984
The therapeutic significance of concomitant antitumor immunity. II. Passive transfer of concomitant immunity with Ly-1+2- T cells primes established tumors in T cell-deficient recipients for endotoxin-induced regression
R J North
Infection and Immunity
|
July 1, 1974
T cell dependence of macrophage activation and mobilization during infection with Mycobacterium tuberculosis
R J North
Infection and Immunity
|
September 1, 1974
Inflammatory lymphocyte in cell-mediated antibacterial immunity: factors governing the accumulation of mediator T cells in peritoneal exudates
R J North, G Spitalny
Immunology
|
September 1, 1990
Elimination of cycling CD4+ suppressor T cells with an anti-mitotic drug releases non-cycling CD8+ T cells to cause regression of an advanced lymphoma
R J North, M Awwad
The Journal of Experimental Medicine
|
October 1, 1986
T cell suppressors of antitumor immunity. The production of Ly-1-,2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity
A DiGiacomo, R J North
Immunology
|
March 1, 1987
Subtherapeutic numbers of tumour-sensitized, L3T4+, Ly 1+2- T cells are needed for endotoxin to cause regression of an established immunogenic tumour
A Digiacomo, R J North
International Journal of Cancer
|
February 15, 1986
Immunological consequences of tumor excision: from active immunity to immunological memory
I Bursuker, R J North
The Journal of Experimental Medicine
|
December 1, 1988
Immunologically mediated regression of a murine lymphoma after treatment with anti-L3T4 antibody. A consequence of removing L3T4+ suppressor T cells from a host generating predominantly Lyt-2+ T cell-mediated immunity
M Awwad, R J North
Page
of 11